Summary

1. Step 5 — Clinical pathway View details →
   Secondary Prevention

   Patient has established atherosclerotic cardiovascular disease. This automatically places them on the secondary-prevention pathway — no risk score is needed to classify risk.

2. Step 6 — Cardiovascular risk View details →
   Very High

   Per standard risk stratification, established atherosclerotic cardiovascular disease is automatically classified Very High risk — no numeric score is calculated.

3. Step 7 — LDL-C target View details →
   <1.4 mmol/L

   Very High risk → target <1.4 mmol/L (and ≥50% reduction from baseline where baseline is known).

4. Step 8 — Treatment plan View details →
   At target — continue current therapy and monitor

   LDL-C is already below target on the current regimen. No escalation needed; recommend routine monitoring.

5. Step 9 — Swiss reimbursement View details →
   Not applicable at this stage

   This engine only activates once a PCSK9 inhibitor (or another reimbursement-restricted therapy) is clinically proposed. For this patient, the Treatment Engine recommended a different next step, so no reimbursement check is needed yet.

Demonstration output based on simplified rules — not clinical advice. Generated 02.11.2026 17:30.